Immunotherapy Fits Everyone? Prognostic Markers for Immune-checkpoint-Inhibitor (ICI) in Non-small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Baptista De Almeida, S. [1 ]
Caleca, T. [1 ]
Silva, M. [1 ]
Honorio, M. [1 ]
Chaves, A. [1 ]
机构：
[1] Hosp Prof Doutor Fernando Fonseca, Med Oncol, Amadora, Portugal
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 10期
关键词：
immune-checkpoint-inhibitor; prognostic markers; non-small cell lung cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P57.01
引用
收藏
页码：S1136 / S1136
页数：1
相关论文
共 50 条
  • [1] Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC)
    Brueckl, Wolfgang M.
    Ficker, Joachim H.
    Zeitler, Gloria
    BMC CANCER, 2020, 20 (01)
  • [2] Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC)
    Wolfgang M. Brueckl
    Joachim H. Ficker
    Gloria Zeitler
    BMC Cancer, 20
  • [3] Chronic immune checkpoint inhibitor (ICI) pneumonitis in patients (pts) with non-small cell lung cancer (NSCLC).
    Stuart, Jessica
    Ricciuti, Biagio
    Alessi, Joao Victor Machado
    Nishino, Mizuki
    Awad, Mark M.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] Imaging of Immune Checkpoint Inhibitor Immunotherapy for Non-Small Cell Lung Cancer
    Shroff, Girish S.
    Strange, Chad D.
    Ahuja, Jitesh
    Altan, Mehmet
    Sheshadri, Ajay
    Unlu, Ebru
    Truong, Mylene T.
    Vlahos, Ioannis
    RADIOGRAPHICS, 2022, 42 (07) : 1956 - 1974
  • [5] Response to neoadjuvant immune checkpoint inhibitor (ICI)-based therapy in oncogenedriven resectable non-small cell lung cancer (NSCLC)
    Rosner, Samuel
    Sivapalan, Lavanya
    Zahurak, Marianna
    Thummalapalli, Rohit
    Rayes, Roni
    Connor, Sydney
    Sanber, Khaled
    Reuss, Joshua E.
    Pereira, Gavin
    Smith, Kellie Nicole
    Anagnostou, Valsamo
    Broderick, Stephen
    Jones, David Randolph
    Brahmer, Julie R.
    Marrone, Kristen A.
    Spicer, Jonathan
    Chaft, Jamie E.
    Forde, Patrick M.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] CheckpointPx: A predictive radiology AI model of immune checkpoint inhibitor (ICI) benefit in non-small cell lung cancer (NSCLC)
    Lee, Seyoung
    Hiremath, Amogh
    Lee, Jeeyeon
    Kim, Haseok
    Zhang, Kai
    Lee, Salie
    Yadav, Monica
    Chung, Liam Il Young
    Kim, Hye Sung
    Djunadi, Trie Arni
    Kim, Yuchan
    Hong, Ilene
    Kang, Grace
    Cho, Amy
    Velichko, Yury
    Gupta, Amit
    Velcheti, Vamsidhar
    Madabhushi, Anant
    Braman, Nathaniel
    Chae, Young Kwang
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [7] Prognostic Immune Markers in Non-Small Cell Lung Cancer
    Suzuki, Kei
    Kachala, Stefan S.
    Kadota, Kyuichi
    Shen, Ronglai
    Mo, Qianxing
    Beer, David G.
    Rusch, Valerie W.
    Travis, William D.
    Adusumilli, Prasad S.
    CLINICAL CANCER RESEARCH, 2011, 17 (16) : 5247 - 5256
  • [8] Prognostic impact of KRAS status in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitor monotherapy
    Pelizzari, G.
    Corvaja, C.
    Targato, G.
    Buriolla, S.
    Bortolot, M.
    Torresan, S.
    Fantin, A.
    De Maglio, G.
    Rossetto, C.
    Rizzato, S.
    Fasola, G.
    Follador, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S1011 - S1011
  • [9] Prognostic factors in non-small cell lung cancer (NSCLC) patients (pts) with brain metastases (BM) treated with immune checkpoint inhibitors (ICI)
    Hendriks, L.
    Henon, C.
    Auclin, E.
    Mezquita, L.
    Ferrara, R.
    Valette, C. Audigier
    Mazieres, J.
    Lefebvre, C.
    Le Moulec, S.
    Duchemann, B.
    Le Pechoux, C.
    Botticella, A.
    Ammari, S.
    Gazzah, A.
    Caramella, C.
    Adam, J.
    Planchard, D.
    De Ruysscher, D.
    Dingemans, A-M. C.
    Besse, B.
    ANNALS OF ONCOLOGY, 2018, 29
  • [10] Prediction of immune checkpoint inhibitor (ICI) response in non-small cell lung cancer (NSCLC) patients using a microbiome-based biomarker
    Robinson, Irina
    Hochmair, Maximilian Johannes
    Jansen, Christian
    Pacifico, Catia
    Sladek, Barbara
    Knabl, Alexander
    Gasche, Nikolaus
    Absenger, Gudrun
    Pichler, Martin
    Valipour, Arschang
    WIENER KLINISCHE WOCHENSCHRIFT, 2022, 134 (19-20) : 742 - 742
12345